• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[外周动脉硬化的药物治疗]

[Pharmacotherapy of peripheral arteriosclerosis].

作者信息

Belousov Iu B, Savenkov P M, Sidel'man A A, Parfenov A S, Savenkov M P

出版信息

Kardiologiia. 1978 Aug;18(8):36-43.

PMID:99596
Abstract

Peripheral atherosclerosis was treated in 178 patients: 90 were given pyridinol carbamate for 2--4 months, 40 pentoxyphylline, 30 cetedil, and 18 received butalamine. in intermittent claudication pyridinol carbamate and trental proved most effective, cetedil (straten) was less effective. The favourable effect of pyridinol carbamate is associated with its action both on the state of microcirculation and on the content of lipids. A significant decrease in the level of blood triglycerides was observed during treatment with pyridinol carbamate. Pentoxyphylline reduced blood viscosity and platelet aggregation in patients with peripheral atherosclerosis but had no effect on the blood lipid content. Cetedil did not reduce blood viscosity although it decreased the aggregation of erythrocytes and inhibited the second phase of platelet aggregation. The objective criterion for the improvement of circulation in the affected extremities was increased tolerance to load, particularly in medication with pyridinol carbamate and trental.

摘要

178例患者接受了外周动脉粥样硬化治疗:90例给予卡胺匹林治疗2 - 4个月,40例给予己酮可可碱,30例给予西替地尔,18例给予布他拉明。在间歇性跛行中,卡胺匹林和曲克芦丁被证明最有效,西替地尔(斯特拉坦)效果较差。卡胺匹林的有益作用与其对微循环状态和脂质含量的作用有关。在用卡胺匹林治疗期间,观察到血液甘油三酯水平显著降低。己酮可可碱降低了外周动脉粥样硬化患者的血液粘度和血小板聚集,但对血脂含量没有影响。西替地尔虽然降低了红细胞聚集并抑制了血小板聚集的第二阶段,但并没有降低血液粘度。改善患肢血液循环的客观标准是对负荷的耐受性增加,特别是在使用卡胺匹林和曲克芦丁治疗时。

相似文献

1
[Pharmacotherapy of peripheral arteriosclerosis].[外周动脉硬化的药物治疗]
Kardiologiia. 1978 Aug;18(8):36-43.
2
Progression of occlusive atherosclerosis. Long-term administration of pyridinol carbamate.
Arch Surg. 1975 Mar;110(3):258-61. doi: 10.1001/archsurg.1975.01360090028006.
3
[Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].[安吉林(吡啶醇氨基甲酸酯)治疗冠状动脉粥样硬化及下肢动脉闭塞性动脉粥样硬化]
Kardiologiia. 1972 Nov;12(11):39-45.
4
[Effect of pyridinol carbamate (Anginin) in peripheral arterial blood circulation disorders].[抗栓丸(安吉林)对周围动脉血液循环障碍的作用]
Med Klin. 1970 Dec 25;65(52):2289-93.
5
[Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
Minerva Cardioangiol. 1974 Jul-Aug;22(7-8):512-42.
6
[Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
Kardiologiia. 1978 Mar;18(3):12-8.
7
The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
Int J Clin Pharmacol Biopharm. 1977 Mar;15(3):135-8.
8
[Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
Med Monatsschr. 1976 Jul;30(7):323-6.
9
[Effectiveness of pentoxifylline and of bio-electromagnetic therapy in lower limb obliterative arterial disease].己酮可可碱与生物电磁疗法治疗下肢闭塞性动脉疾病的疗效
Orv Hetil. 2013 Oct 20;154(42):1674-9. doi: 10.1556/OH.2013.29693.
10
[Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
Z Gesamte Inn Med. 1989 Feb 1;44(3):77-9.